Incidence of sinusoidal obstruction syndrome following mylotarg (gemtuzumab ozogamicin): A prospective observational study of 482 patients in routine clinical practice
Martin S. Tallman*, George B. McDonald, Laurie D. Deleve, Maria R. Baer, Michael N. Cook, G. Jay Graepel, Carl Kollmer
Dive into the research topics of 'Incidence of sinusoidal obstruction syndrome following mylotarg (gemtuzumab ozogamicin): A prospective observational study of 482 patients in routine clinical practice'. Together they form a unique fingerprint.